Prediction of the pharmacokinetic parameters of reduced- dolasetron in man using in vitro-in vivo and interspecies allometric scaling

By Sanwald-Ducray P.   Dow J.  

Xenobiotica, Vol. 27, Iss. 2, 1997-02 ,pp. : 189-201

Informa Healthcare

Access to resources Recommend Favorite

In vitro–in vivo extrapolation of hepatic clearance: Biological tools, scaling factors, model assumptions and correct concentrations

By Pelkonen O.   Turpeinen M.  

Xenobiotica, Vol. 37, Iss. 10-11, 2007-11 ,pp. : 1066-1089

Informa Healthcare

Access to resources Recommend Favorite

Determination of microsome and hepatocyte scaling factors for in vitro/in vivo extrapolation in the rat and dog

By Smith R.   Jones R. D. O.   Ballard P. G.   Griffiths H. H.  

Xenobiotica, Vol. 38, Iss. 11, 2008-11 ,pp. : 1386-1398

Informa Healthcare

Access to resources Recommend Favorite

The volume of distribution is an indicator of poor in vitro-in vivo extrapolation of clearance for acidic drugs in the rat

By Sohlenius-Sternbeck Anna-Karin   Fagerholm Urban   Bylund Johan  

Xenobiotica, Vol. 43, Iss. 8, 2013-08 ,pp. : 671-678

Informa Healthcare

Access to resources Recommend Favorite

Prediction of in vivo drug clearance from in vitro data. I: Impact of inter-individual variability

By Howgate E. M.   Rowland Yeo K.   Proctor N. J.   Tucker G. T.   Rostami-Hodjegan A.  

Xenobiotica, Vol. 36, Iss. 6, 2006-06 ,pp. : 473-497

Informa Healthcare

Access to resources Recommend Favorite